Significant Ownership of Seven Fleet Partners LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Seven Fleet Partners LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Dr. Brian Liu - Dr. Brian Liu, Managing Member of Seven Fleet Advisors, LLC, its Investment Manager
- Manager location
- Mountain View, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Seven Fleet Partners LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Seven Fleet Partners LP
Significant Ownership of Seven Fleet Partners LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | Common Stock, par value $0.0001 per share | 1.9% | $39,333,320 | 1,515,151 | Seven Fleet Partners LP | 11 Sep 2025 | ||
| CTMX | CytomX Therapeutics, Inc. | Common Stock, $0.00001 par value per share | 0.2% | $267,784 | 377,161 | Seven Fleet Partners LP | 13 May 2025 |
Schedules 13D/G Reported by Seven Fleet Partners LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.